Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion.(b)(4).
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 7, 2018.(b)(4).The returned sample was visually inspected with no anomalies noted.The unit was then pressurized with air (as received) up to 1030 mmhg, submerged in a water bath, and no leak were noted.The large blue cap was then loosened and retightened with a calibrated torque wrench to production specification, it was then pressurized with the air, submerged in a water bath.No leak was noted.A retention sample from the same lot number was visually inspected and confirmed to have no traces of buffer on the outside of the unit or inside the pouch.It was then leak tested, pressurized up to 1030 mmhg.A leak was observed from the large bore cap after approximately 5 seconds.The root cause for the retention sample leak is a lack of sealing between the large bore adapter (blue cap) and the shunt sensor body.When the large blue vent cap is tightened, interference between the threads of the cap and the shunt sensor body exist, causing inadequate seal leading to a leak.However, the complaint was not confirmed, and a definitive root cause was not able to be determined.It is possible that the buffer solution was not completely wiped off the product after buffer fill during manufacturing.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|